Martin Babler
2018
In 2018, Martin Babler earned a total compensation of $2.3M as President and Chief Executive Officer at Principia Biopharma, a 94% increase compared to previous year.
Compensation breakdown
| Bonus | $302,000 |
|---|---|
| Option Awards | $1,530,838 |
| Salary | $447,128 |
| Other | $41,206 |
| Total | $2,321,172 |
Babler received $1.5M in option awards, accounting for 66% of the total pay in 2018.
Babler also received $302K in bonus, $447.1K in salary and $41.2K in other compensation.
Rankings
In 2018, Martin Babler's compensation ranked 4,989th out of 14,244 executives tracked by ExecPay. In other words, Babler earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,989 out of 14,244 | 65th |
Division Manufacturing | 1,876 out of 5,765 | 68th |
Major group Chemicals And Allied Products | 689 out of 2,128 | 68th |
Industry group Drugs | 576 out of 1,817 | 68th |
Industry Pharmaceutical Preparations | 443 out of 1,391 | 68th |
Source: SEC filing on April 26, 2019.
Babler's colleagues
We found two more compensation records of executives who worked with Martin Babler at Principia Biopharma in 2018.